PL397785A1 - Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process - Google Patents
Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging processInfo
- Publication number
- PL397785A1 PL397785A1 PL397785A PL39778512A PL397785A1 PL 397785 A1 PL397785 A1 PL 397785A1 PL 397785 A PL397785 A PL 397785A PL 39778512 A PL39778512 A PL 39778512A PL 397785 A1 PL397785 A1 PL 397785A1
- Authority
- PL
- Poland
- Prior art keywords
- thioproline
- ergothioneine
- composition
- preparation containing
- extrinsic aging
- Prior art date
Links
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Wynalazek dotyczy kompozycji zawierajacej tioproline i ergotioneine w synergicznie skutecznej ilosci oraz preparatu zawierajacego tioproline i ergotioneine w synergicznie skutecznej ilosci. Wynalazek dotyczy ponadto zastosowania kompozycji zawierajacej tioproline i ergotioneine do spowalniania, przeciwdzialania, zapobiegania procesowi starzenia zewnatrzpochodnego oraz sposobu spowalniania, przeciwdzialania, zapobiegania procesowi starzenia zewnatrzpochodnego skóry.The invention relates to a composition containing thioproline and ergotioneine in a synergistically effective amount and a preparation containing thioproline and ergotioneine in a synergistically effective amount. The invention further relates to the use of a composition containing thioproline and ergotioneine for slowing, counteracting, preventing extrinsic aging and a method of slowing down, counteracting, preventing extrinsic aging.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL397785A PL223232B1 (en) | 2012-01-12 | 2012-01-12 | Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL397785A PL223232B1 (en) | 2012-01-12 | 2012-01-12 | Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process |
Publications (2)
Publication Number | Publication Date |
---|---|
PL397785A1 true PL397785A1 (en) | 2013-07-22 |
PL223232B1 PL223232B1 (en) | 2016-10-31 |
Family
ID=48877630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL397785A PL223232B1 (en) | 2012-01-12 | 2012-01-12 | Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL223232B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023150241A1 (en) * | 2022-02-03 | 2023-08-10 | Trampota Jan | Commensal signalling compounds for treating or preventing microbiome dysfunction in the skin or mouth |
-
2012
- 2012-01-12 PL PL397785A patent/PL223232B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL223232B1 (en) | 2016-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016500511A1 (en) | Selective grp94 inhibitors and uses thereof | |
BR112016014410A2 (en) | neoantigen vaccine combination therapy | |
PH12014502757B1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
NZ628294A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
MY197723A (en) | Vaccine compositions for the prevention of dengue virus infection | |
PH12014502875A1 (en) | Vaccine compositions for prevention against dengue virus infection | |
NZ702087A (en) | Pharmaceutical compositions and treatment of mastitis | |
PH12015502405B1 (en) | Methods and compositions for wound healing | |
PH12017500615A1 (en) | Ophthalmic composition comprising cyclosporine and trehalose | |
EP3061452A4 (en) | Use of icaritin in preparing medicament for preventing or treating hematocytopenia | |
UY34896A (en) | TREATMENT OF MULTIPLE SCLEROSIS WITH A COMBINATION OF LAQUINIMOD AND FAMPRIDINE | |
MX2015012580A (en) | The use of sdf-1 to mitigate scar formation. | |
MX2015013240A (en) | A method of providing ocular neuroprotection. | |
EA201591507A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS BY LACHINIMODOM | |
HK1210163A1 (en) | Compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
EA201491581A1 (en) | ВЕЗИКУЛЯРНЫЕ КОМПОЗИЦИИ | |
EP2910247A4 (en) | Compositions for preventing or treating allergic skin disorders, containing gpcr19 agents as active ingredients | |
UA113859C2 (en) | SPIROTIENOPIRAN-PIPERIDINE DERIVATIVES AS AN ORL-1 RECEIVER ANTAGONS FOR THEIR APPLICATION IN THE TREATMENT OF ALCOHOLIC DEPENDENCE AND ABUSE | |
HK1215682A1 (en) | Compositions, uses and methods for treating or preventing dental caries | |
PL397785A1 (en) | Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process | |
MX362111B (en) | A method of improving liver function. | |
EP2838546A4 (en) | Methods and compositions for treating wounds and reducing the risk of incisional hernias | |
PL402105A1 (en) | Composition and formulation containing rosmarinic acid and thioproline, the use of this composition and a method for protecting the skin from the outside originating aging | |
NZ629475A (en) | Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines | |
PT2686005T (en) | Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |